Study of Daily Pentoxifylline as a Rescue Treatment in Duchenne Muscular Dystrophy

NCT00243789 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

64

Enrollment

NETWORK

Sponsor class

Conditions

Muscular Dystrophy, Duchenne

Interventions

DRUG: Pentoxifylline

Sponsor

Cooperative International Neuromuscular Research Group